DUROCTO Trademark

Trademark Overview

On Thursday, July 24, 2014, a trademark application was filed for DUROCTO with the United States Patent and Trademark Office. The USPTO has given the DUROCTO trademark a serial number of 79152764. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, April 22, 2022. This trademark is owned by Novo Nordisk Health Care AG. The DUROCTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hemostasis management
durocto

General Information

Serial Number79152764
Word MarkDUROCTO
Filing DateThursday, July 24, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, April 22, 2022
Registration Number4824269
Registration DateTuesday, October 6, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for hemostasis management

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH-8050 Zürich
CH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH-8050 Zürich
CH

Trademark Events

Event DateEvent Description
Monday, March 13, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, February 15, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, February 14, 2023INVALIDATION PROCESSED
Thursday, December 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 22, 2022CANCELLED SECTION 71
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Sunday, November 21, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, May 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 29, 2016FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 29, 2016FINAL DISPOSITION PROCESSED
Wednesday, January 6, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Friday, July 17, 2015NOTIFICATION PROCESSED BY IB
Wednesday, July 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 1, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 1, 2015NOTICE OF PUBLICATION
Friday, June 12, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 11, 2015ASSIGNED TO LIE
Friday, May 22, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 22, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 22, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 22, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 18, 2015NON-FINAL ACTION MAILED
Sunday, May 17, 2015NON-FINAL ACTION WRITTEN
Friday, December 5, 2014REFUSAL PROCESSED BY IB
Friday, November 14, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 14, 2014REFUSAL PROCESSED BY MPU
Thursday, November 13, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 12, 2014NON-FINAL ACTION WRITTEN
Thursday, November 6, 2014ASSIGNED TO EXAMINER
Friday, October 10, 2014APPLICATION FILING RECEIPT MAILED
Monday, October 6, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 2, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

durocto management hemostasis preparations pharmaceutical